Jones, R. W., Bayer, A. J., Wilkinson, D., Paterson, K. R., Jenkins, L., Bullock, R., …Millais, S. B. (2005). Evaluation of the safety and immunogenicity of synthetic Aβ42 (AN1792) in patients with AD. Neurology, 64(1), 94-101. https://doi.org/10.1212/01.WNL.0000148604.77591.67